Lauren Weiniger

Lauren is a serial entrepreneur with a passion for creating models that generate impact and profit simultaneously. Prior to joining Refractal, Lauren co-founded SAFE Health and The SAFE App (Now Safely App), a premier telemedicine and diagnostics company focused on the underserved market of sexual health. A graduate of Oxford University, Lauren began her career at Citigroup and was the first employee at TAU Investment Management, an impact investment private equity fund in New York City, and also oversaw a portfolio of biotech companies for Abraxis Bioscience, which was acquired by Celgene for $2.3B.